GI Dynamics - Adjournment of Special Meeting
22 February 2018 AEDT
BOSTON and SYDNEY - 22 February 2018 - GI Dynamics®, Inc. (ASX:GID), a medical device company that is developing EndoBarrier®, held a Special Meeting on Wednesday, 21 February 2018 at 3:00pm United States Eastern Standard Time (EST) │Thursday, 22 February 2018 at 7:00am Australian Eastern Daylight Time (AEDT). The Special Meeting was adjourned until Tuesday, 27 February 2018 at 3:00pm EST │ Wednesday, 28 February 2018 at 7:00am AEDT.
New date and time for Special Meeting: Tuesday, 27 February 2018 at 3:00pm EST │ Wednesday, 28 February 2018 at 7:00am AEDT
Location: The offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Centre, Boston, MA 02111
The business of the Special Meeting will remain as set out in the proxy statement previously announced on 7 February 2018 and sent to stockholders on or about this date. The details to attend the Special Meeting by telephone also remains as announced on 7 February 2018.
Investor Relations
United States: Janell Shields +1 (781) 357-3280
Proxies cast in relation to the Special Meeting remain valid unless withdrawn prior to the resumed meeting. Any additional proxy forms for the adjourned meeting must be received by the Registrar by Monday, 26 February 2018 at 7:00am AEDT (which is Sunday, 25 February 2018 at 3:00pm EST), being not later than 48 hours before the commencement of the adjourned Special Meeting. Any additional CDI voting instruction forms for the adjourned meeting must be received by the Registrar by Sunday, 25 February 2018 at 7:00am AEDT (which is Saturday, 24 February 2018 EST at 3:00pm),
investor@gidynamics.com being not later than 72 hours before the commencement of the adjourned Special
Meeting.
Accessing the teleconference:
22 February 2018 AEDT
Please dial in five minutes prior to the start of the call. Regional dial in number are as follows:
United States
Dial Toll Free
877.407.6184
Australia Dial Toll Free 1.800.687.004
Germany Dial Toll Free 0.800.182.0040
United Kingdom Dial Toll Free 0.800.756.3429
Switzerland
Dial Toll Free
800.835.525
For all other regions or if you are unable to access the call through any of the above numbers please dial the toll number as follows:
Other InternationalDial Toll
201.389.0877
About GI Dynamics
GI Dynamics®, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device therapy for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale and is limited by federal law to investigational use only. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. For more information please visitwww.gidynamics.com.
###
Investor Relations
United States: Janell Shields +1 (781) 357-3280investor@gidynamics.com
GI Dynamics Inc. published this content on 22 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 February 2018 22:45:06 UTC.
Original documenthttps://wcsecure.weblink.com.au/clients/gidynamicq4/headline.aspx?headlineid=21066387
Public permalinkhttp://www.publicnow.com/view/1EFD96C906A820CDE508E59898F0A0185AAB7BB4